Lymphoma clinical trials in Iowa
6 studies for Lymphoma are looking for participants at sites in Iowa.
Cities in Iowa
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
- University of Iowa, Iowa City
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT07221500Collection of Tissue Samples for Cancer Research
- University of Iowa, Iowa City
RecruitingObservational study
2 Months · All sexes · Updated Sep 16, 2026 · NCT00900198A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma
- University of Iowa, Iowa City
- University of Iowa Health Care, Waukee
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 3, 2026 · NCT06084936Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
- University of Iowa, Iowa City
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 25, 2026 · NCT05826535A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
- University of Iowa Health, Iowa City
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 21, 2026 · NCT07192471A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
- University of Iowa, Iowa City
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 4, 2026 · NCT07188558From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.